Clinical Trials Directory

Trials / Conditions / Human Papillomavirus

Human Papillomavirus

72 registered clinical trials studyying Human Papillomavirus5 currently recruiting.

StatusTrialSponsorPhase
Active Not RecruitingFeasibility of Intravaginal Artesunate as Adjuvant HPV & Cervical Precancer Treatment in Kenya
NCT06519994
UNC Lineberger Comprehensive Cancer CenterPhase 2
CompletedKnowledge of 18-19 Years Old About Papillomavirus and HPV Vaccination
NCT07418203
Université de Reims Champagne-Ardenne
Active Not RecruitingComparisons of the Effects and Clinical Outcomes of CH2 Vaginal Gel Versus Placebo on CIN1
NCT06582004
National Taiwan University HospitalN/A
RecruitingEvaluation of a Novel Point-of-Care Diagnostic Test for Human Papillomavirus (HPV)
NCT06434337
M.D. Anderson Cancer Center
CompletedAcceptability and Feasibility of Combination Treatment for Cervical Precancer Among South African Women Living
NCT05413811
UNC Lineberger Comprehensive Cancer CenterN/A
RecruitingComparing Immune Response of 2 vs 3 HPV Doses (27-45 Years Old)
NCT05672927
The University of Texas Medical Branch, GalvestonPhase 4
RecruitingMulti-site HPV Screening by High-throughput Sequencing in Patients With Chronic HPV-HR Infection Followed by G
NCT04901351
University Hospital, ToulouseN/A
RecruitingProvider Recommendation and HPV Vaccination
NCT05365048
Kaiser PermanenteN/A
RecruitingNatural History, Epidemiology and Pathogenesis of Severe HPV-Related Diseases (Neptune)
NCT05026138
National Institute of Allergy and Infectious Diseases (NIAID)
Active Not RecruitingA Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Sm
NCT04708470
National Cancer Institute (NCI)Phase 1 / Phase 2
CompletedAlinity m HR HPV Specimen Collection Study From Women Undergoing Routine Cervical Cancer Screening
NCT04746872
Abbott Molecular
UnknownComparing Strategies for Implementing Primary HPV Screening
NCT04371887
Chun ChaoN/A
UnknownHPV Integration and Tumorigenesis of Uterine Cervical Adenocarcinoma
NCT03742869
Lei Li
TerminatedImmunotherapy With E6 T Cell Receptor (TCR) T Cells for Vulvar High-Grade Squamous Intraepithelial Lesions
NCT03197025
National Cancer Institute (NCI)Phase 1
Completedtxt2protect: Using Text Messaging to Increase HPV Vaccination Among Young Sexual Minority Men
NCT02994108
Northwestern UniversityN/A
CompletedLong Term Immune Memory Responses to HPV Vaccination Following 2 vs 3 Doses of Quad-HPV Vaccine
NCT02968420
University of British ColumbiaPhase 4
UnknownLongitudinal HPV Pap in CIN and VAIN
NCT05931354
Chang Gung Memorial Hospital
CompletedIncreasing Uptake of Evidence-Based Screening Services Through CHW-led Multi-modality Intervention
NCT02970136
University of MiamiN/A
CompletedSafety and Tolerability of GX-I7 in HPV-infected Female Volunteers
NCT03144934
Genexine, Inc.Phase 1
CompletedHuman Papillomavirus in Young People Epidemiological Research 2 (HYPER2)
NCT03000933
The Alfred
CompletedTailoring of Vaccine-Focused Messages: Disease Salience
NCT03002324
Emory UniversityN/A
CompletedEffect of Human Papillomavirus Self-Collection on Cervical Cancer Screening in High Risk Women: My Body, My Te
NCT02651883
UNC Lineberger Comprehensive Cancer CenterN/A
CompletedEvaluating the 2-dose Immunization Schedule of Human Papillomavirus (HPV)-16/18 in Adolescent Females
NCT02740777
Shanghai Zerun Biotechnology Co.,LtdPhase 2
CompletedA Retrospective Chart Review Study of Gene-Eden-VIR/Novirin
NCT02715752
The Center for the Biology of Chronic Disease
UnknownSafety and Efficacy Study of TVGV-1 Vaccine to Treat HPV Induced Cervical HSIL
NCT02576561
THEVAX Genetics VaccinePhase 2
TerminatedThe HPV-SAVE Study Team: HPV Screening and Vaccine Evaluation in Men Who Have Sex With Men
NCT02503111
University Health Network, TorontoN/A
TerminatedAccuracy of Portable Colposcopy and HPV Genotypes Among HIV+ Women
NCT02338141
Duke UniversityN/A
CompletedNormalizing HPV Vaccination in Preteens With a Serious Video Game
NCT04627298
University of North Carolina, Chapel HillN/A
CompletedPredictors of CIN Study Series 5.0:Stability Study in Vaginal Self-samples
NCT02622997
Queen Mary University of LondonN/A
CompletedMaking Effective Human Papillomavirus (HPV) Vaccine Recommendations
NCT02377843
University of North Carolina, Chapel HillN/A
CompletedA Cohort Study to Assess Sustained Immunogenicity to qHPV Vaccine Among HIV-infected Girls and Boys Age 9-14 Y
NCT01446718
Kenya Medical Research Institute
CompletedInteractive, Health Literacy Promoting Text Messages and HPV Vaccine Completion In Minority Adolescents
NCT02236273
Columbia UniversityN/A
CompletedLongitudinal Clinical Evaluation of the HPV Assay on the BD VIPER LT System With Cervical Specimens
NCT02267876
Becton, Dickinson and Company
CompletedVideo to Promote HPV Vaccination
NCT02196454
Children's Hospital of PhiladelphiaN/A
UnknownSurvey of Predictors of Human Papillomavirus (HPV) Vaccination Among Parents of Rural Adolescent Girls in Myso
NCT01307774
Purnima Madhivanan
CompletedPrevalence of Genital HPV Infection in Males Following Introduction of Universal Male HPV Vaccination
NCT02003508
The Alfred
CompletedPrevention of HPV in the School Health Service
NCT02280967
Uppsala UniversityN/A
UnknownThe Princess Alexandra Hospital and the QIMR Berghofer Medical Research Institute Head and Neck Cancer Study
NCT02126189
Queensland Centre of Excellence for Head and Neck Cancer
CompletedImmunogenicity and Safety of Human Papillomavirus (HPV)-16/18 Vaccine in Healthy Females
NCT02740790
Shanghai Zerun Biotechnology Co.,LtdPhase 2
CompletedStudy of Gardasil in Mid-Adult Males (MAM)
NCT01432574
H. Lee Moffitt Cancer Center and Research InstitutePhase 2
CompletedStudy of the Diagnostic Efficacy of "Real Time" Niris 1300e Optical Coherence Tomography (OCT) Imaging System
NCT01766284
Preventive Oncology International, Inc.N/A
CompletedEvaluation of Immune Response Against Human Papillomavirus (HPV)in Patients With Metastatic Cancer of the Anal
NCT01845779
Centre Hospitalier Universitaire de BesanconN/A
CompletedA Study to Compare the Impact of a School Based HPV Program on Vaccination Uptake and Completion Rates
NCT01526551
Lake Cumberland District Health DepartmentN/A
CompletedA Phase I Clinical Trial of an HPV Therapeutic Vaccine
NCT01653249
University of ArkansasPhase 1
CompletedDetection of Human Papillomavirus in Polymerase Chain for Suspicious Lesions of the Amygdala: Concordance Smea
NCT02656576
University Hospital, ToulouseN/A
UnknownEvaluate the Safety of Recombinant Human Papillomavirus Bivalent (Types 16 and 18) Vaccine (Yeast) in Healthy
NCT01548118
Shanghai Zerun Biotechnology Co.,LtdPhase 1
CompletedHuman Papillomavirus in Menstrual Blood
NCT01506128
Seoul National University Hospital
CompletedChinese Cancer Prevention Study(CHICAPS)
NCT01524003
Preventive Oncology International, Inc.N/A
UnknownPsychosocial Effect of HPV Positivity
NCT01459289
The University of Hong KongN/A
CompletedImmune Response to Bivalent and Tetravalent Human Papillomavirus Vaccine in HIV Infected Adults
NCT01386164
University of AarhusPhase 4
CompletedInfluence of U-relax on Vaginal Health Promotion and HPV DNA Test Change From Positive to Negative
NCT01599416
Chang Gung Memorial HospitalN/A
CompletedPrevalence, Persistence, and Risk Factors for Oral Human Papillomavirus (HPV) Infections in College Women
NCT01289873
University of Florida
CompletedThe Development of a "Mother/Child, Screen, Treat and Vaccinate Program" in Manchay and Iquitos, Peru
NCT01338051
Preventive Oncology International, Inc.Phase 1
CompletedTesting the Use of Prompts to Increase Adolescent Immunization Rates
NCT01984125
University of California, Los AngelesN/A
UnknownKAP/WTP and HPV Prevalence Studies in a Developing World Setting (Bamako, Mali)
NCT01314404
Global Alliance to Immunize Against AIDS Vaccine Foundation
CompletedImmunogenicity and Tolerability of V503 Versus GARDASIL (V503-009)
NCT01304498
Merck Sharp & Dohme LLCPhase 3
CompletedRole of Immune Activation in Response of Head and Neck Squamous Cell Carcinoma to Therapy
NCT01358097
Icahn School of Medicine at Mount Sinai
CompletedStudy of the Prevention of Anal Cancer
NCT02007421
Kirby InstituteN/A
CompletedAn HPV Vaccine Provider Intervention in Safety Net Clinics
NCT02808832
Meharry Medical CollegeN/A
CompletedHuman Papillomavirus (HPV) Vaccination in Barretos (Pio XII Foundation - Barretos Cancer Hospital)
NCT01159834
Barretos Cancer Hospital
CompletedHuman Papillomavirus (HPV) Infection in Young Men Who Have Sex With Men
NCT01422356
The Alfred
CompletedVax Facts Human Papillomavirus (HPV): Study of a Computer-based Tailoring System and Mothers' Intentions to Va
NCT01143142
University of MichiganN/A
CompletedHuman Papillomavirus (HPV) Vaccination Among Survivors of Childhood Cancer
NCT01117389
St. Jude Children's Research Hospital
CompletedA Comparison Study of Two Community Outreach-Based Approaches to Increase Participation of Women Living in the
NCT01058148
National Cancer Institute (NCI)
CompletedHuman Papillomavirus (HPV) Oral Transmission Study in Partners Over Time
NCT01342978
Johns Hopkins Bloomberg School of Public Health
CompletedHuman Papilloma Virus (HPV) Vaccination Among Rural African American Primary Caregivers and Daughters
NCT00937287
University of Georgia
CompletedImmunogenicity of Gardasil and Twinrix and the Effect of a Dose of Gardasil or Cervarix Given 42 Months Later.
NCT01456715
Laval UniversityPhase 3
UnknownClinicopathological and Molecular Correlation of Acrochordon in Relation to Human Papillomavirus Infection
NCT00520078
National Taiwan University Hospital
CompletedNatural History of HPV Infection in Men: The HIM Study
NCT00786760
H. Lee Moffitt Cancer Center and Research Institute
CompletedA Multi-center Survey of HPV in Cervical Intraepithelial Neoplasia (CIN) With Longitudinal Follow-up of LSIL C
NCT00201370
National Health Research Institutes, Taiwan
Unknown102 Annual Pap Smear Screening Database Maintenance Project
NCT02063152
National Taiwan University Hospital
CompletedNatural History of HPV From Infection to Neoplasia in Adolescents and Young Women
NCT01366742
University of California, Los Angeles